(1)
RavasioR.; AntonelliS.; MaiorinoA.; CostanzoA.; LosiS. Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-to-Severe Plaque Psoriasis in Italy. GRHTA 2019, 6.